Tizoxanide Inhibits Inflammation in LPS-Activated RAW264.7 Macrophages via the Suppression of NF-κB and MAPK Activation
Authors:
- 2 April 2019
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 42 (4) , 1336-1349
Abstract
Tizoxanide is the main active metabolite of nitazoxanide. Nitazoxanide and tizoxanide have a broad-spectrum anti-infective effect, including parasites, bacteria, and virus. In the present study, we investigated the anti-inflammatory effect of tizoxanide on lipopolysaccharide (LPS)-stimulated RAW264.7 cells and revealed underlying molecular mechanisms. The results showed that tizoxanide significantly suppressed production of NO as well as pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α in dose-dependent manner. Meanwhile, the levels of gene expression of these cytokines were inhibited significantly by tizoxanide that was discovered using RT-PCR. The increased protein levels of inducible nitric oxide synthase, heme oxygenase-1, and cyclooxygenase-2 by LPS in the cells were also reduced by tizoxanide. Moreover, we found that tizoxanide inhibited the phosphorylation of IKK-α and degradation of IκB by LPS in macrophage cells. The increased protein levels of p65 induced by LPS in the cytoplasm and nucleus were both decreased by tizoxanide, and the nuclear translocation of p65 was also restrained in cell imaging. In addition, tizoxanide considerably also inhibited LPS-activated JNK, p38, and ERK phosphorylation in RAW264.7 cells. Taken together, our results suggested that tizoxanide exerts anti-inflammatory effects, by inhibiting the production of pro-inflammatory cytokines and suppressing of the activation of the NF-κB and the MAPK signaling pathways in LPS-treated macrophage cells.Keywords
Funding Information
- the National Key Technology Research and Development Program of China (2015BAD11B00)
- the national key Research and Development Program of China (2018YFD0500302)
- The National Natural Science Foundation of China (31872516)
This publication has 45 references indexed in Scilit:
- Nitazoxanide Stimulates Autophagy and Inhibits mTORC1 Signaling and Intracellular Proliferation of Mycobacterium tuberculosisPLOS Pathogens, 2012
- Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer propertiesInternational Immunopharmacology, 2012
- Thiazolides as Novel Antiviral Agents. 1. Inhibition of Hepatitis B Virus ReplicationJournal of Medicinal Chemistry, 2011
- The cationic amphiphile 3,4-bis(tetradecyloxy)benzylamine inhibits LPS signaling by competing with endotoxin for CD14 bindingBiochemical Pharmacology, 2010
- Nitazoxanide Inhibits Biofilm Formation by Staphylococcus epidermidis by Blocking Accumulation on SurfacesAntimicrobial Agents and Chemotherapy, 2010
- Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational LevelJournal of Biological Chemistry, 2009
- TLRs and innate immunityBlood, 2009
- Inflammation and cancer: Role of nuclear factor‐kappaB activationCancer Science, 2008
- Coordinated binding of NF-κB family members in the response of human cells to lipopolysaccharideProceedings of the National Academy of Sciences, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006